BRD7P3

Across TCGA pan-cancer cohorts, BRD7P3 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated BRD7P3 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher BRD7P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BRD7P3 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LIHC show a favorable association.

LUSC, SKCM, and UVM are the cancer types where BRD7P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	IV	0.001	0.673	.014	58	view →
SKCM	OS	Tertile	All	0.858	0.747	<.001	57	view →
UVM	DFS	Tertile	All	0.358	0.615	.011	30	view →
LIHC	DFS	Tertile	III,IV	0.624	0.239	.015	24	view →
DLBC	OS	Quartile	II,III,IV	0.624	0.958	.007	20	view →
ACC	OS	Median	III,IV	0.808	0.421	.012	17	view →
GBM	OS	Tertile	All	0.597	0.328	.005	12	view →
THYM	DFS	Tertile	IV	0.407	1.000	.026	9	view →
KIRP	DFS	Quartile	III,IV	0.927	0.632	.031	6	view →
ESCA	OS	Tertile	IV	0.373	0.916	.024	6	view →
KIRC	DFS	Median	III,IV	0.360	0.546	.038	3	view →
LUAD	DFS	Tertile	III,IV	0.758	0.559	.031	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

BRD7P3–LUSC (OS)

Open the LUSC breakdown →